** Shares of healthcare product distributor Henry Schein HSIC.O fall 1.7% to $76.31
** Co forecasts 2025 profit between $4.80 and $4.94 per share, lower than analysts' estimates of $4.99, per data compiled by LSEG
** HSIC reports Q4 profit of $1.19/share vs est of $1.21/share
** Total Q4 sales of $3.2 bln misses est of $3.29 bln
** HSIC expects revenue to grow by 2% to 4% from the $12.67 bln reported in 2024
** Stock has fallen 2.7% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.